Marks MTS' third new partner in the last 12 monthsNEW YORK, May 2, 2024 /PRNewswire/ -- MTS Health Partners is pleased to announce the addition of Jason Schoenholtz as Partner with the Firm. This strategic addition bolsters MTS' healthcare services team, demonstrating the Firm's commitment to expanding its capabilities and delivering exceptional value to clients in the rapidly evolving healthcare landscape."Jason's expertise across the healthcare sector aligns perfectly with our strategic vision of expanding the Firm's coverage while providing comprehensive solutions to our clients through deep content knowledge," said MTS Founding Partner Curtis Lane. "His addition reinforces our dedication to delivering innovative strategies and driving growth in the healthcare industry."In his role, Jason will identify new opportunities, navigate complex transactions, and drive value for clients across the healthcare services continuum. "I am thrilled to join MTS Health Partners and embark on this exciting new chapter in my career. The Firm's reputation for taking an innovative, client-centric approach, and commitment to excellence align perfectly with my own values and objectives. I am eager to leverage my experience and expertise to contribute to the Firm's continued success."Jason joins MTS from Lazard, where he focused on the healthcare supply chain including med-surg/drug distribution, durable medical equipment (DME), home medical supplies, pharmacy, pharma outsourcing, and medical/dental products.Jason holds a Bachelor of Science degree in Mechanical Engineering from the University of Vermont, a Master of Science in Bioengineering from the University of Pennsylvania, and an MBA in Finance and Healthcare Management from the Wharton School of the University of Pennsylvania

NEW YORK, Aug. 14, 2023 /PRNewswire/ -- MTS Health Partners ("MTS"), a leading healthcare-dedicated investment bank that provides strategic and financial advice to the global healthcare industry, announced today that Daun Chung has joined the firm as a Partner in its New York office.

Appointment Bolsters Firm's Deep Commitment to Healthcare Technology CoverageNEW YORK, June 6, 2023 /PRNewswire/ -- MTS Health Partners ("MTS"), a leading healthcare-dedicated investment bank that provides strategic and financial advice to the global healthcare industry, announced today that Ryan Stewart has joined the firm as a Partner in its New York office. As a key member of the MTS team, Ryan will work with Michael Ludwig to drive the firm's strategic initiatives in the rapidly evolving healthcare technology sector and expand the firm's industry-leading Healthcare Technology team.Ryan brings more than 25-years of industry experience and expertise, having worked in the healthcare technology field as an operating executive, management consultant, equity research analyst and investment banker. With more than 15-years in investment banking, most recently as a Managing Director at Solomon Partners, and prior to that as a Managing Director at SVB Securities, he brings unique experience and deep relationships across the sector, having built and led both firms' Healthcare Technology & Tech-Enabled Services practices.Appointment of Ryan Stewart Bolsters MTS' Deep Commitment to Healthcare Technology Coverage Tweet this"We are thrilled to welcome Ryan to the MTS team," said Curtis Lane, Founding Partner of MTS. "I have known and followed Ryan's career for many years, and his hiring reflects our commitment to expand our expertise in healthcare technology and reinforces our position as an industry leading advisor.""I am deeply honored to join MTS," said Ryan. "I am very excited to collaborate with my new partners on scaling our healthcare technology presence across the core and essential end-markets of healthcare, including care delivery, value-based care, managed care, provider-tech, pharma-tech and the emerging application of data & analytics across the entire industry."Over the past 18-months, Ryan has advised on ~$2 billion of M&A volume, including the sale of Panalgo to WCAS and Hg-owned MMIT/Evaluate; the sale of Patient Funding Alternatives to Leonard Green & Partners; the $1.35 billion purchase of MagellanRx by Prime Therapeutics; and the sale of Prodigo Solutions to Temasek and Warburg Pincus-backed GHX.MTS has significant experience representing public and private healthcare companies on a broad range of transactions, including M&A and strategic advisory assignments, as well as privately negotiated financings across a wide range of structures. Most recently, the firm served as financial advisor to both CTI BioPharma on its $1.7 billion sale to Swedish Orphan Biovitrum (SOBI) and to Seagen on its $43 billion sale to Pfizer.About MTSMTS Health Partners is a leading healthcare-dedicated investment bank that provides strategic and financial advisory services to the global healthcare industry